Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00096005 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
36
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)